US refuses to compel lower prices for Pfizer and Astellas cancer drug

23-03-2023

Liz Hockley

US refuses to compel lower prices for Pfizer and Astellas cancer drug

Halawi / Shutterstock.com

NIH rejects petition to use “march-in” rights to allow cheaper competition | Xtandi is “widely available” to public, federal agency says.


Xtandi, Pfizer, Astella, National Institutes of Health, march-in rights

LSIPR